A coronary artery calcium scan is a short, low-dose CT that measures calcium buildup in the arteries feeding the heart. It can help show whether a statin is warranted.
A 2026 analysis published in the Journal of the American College of Cardiology put hard numbers on the difference. Among adults not currently flagged for statin treatment, cardiovascular event rates were just 1.2 per 1,000 person-years when the calcium score was zero, compared with 4.5 per 1,000 person-years when any calcium was present.
The analysis was published in the Journal of the American College of Cardiology in 2026. It matters because millions of American adults sit in the borderline zone where guidelines neither clearly recommend a statin nor rule it out.
The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline expanded the role of CAC scoring as a tool for guiding treatment in exactly this group.
Also read: Heart doctor warns: Many men ignore these warning signs
What the score actually means
Interpretation follows tiered thresholds. A score of zero supports considering statin deferral in carefully selected patients without strong risk enhancers, according to a 2026 review in Frontiers in Radiology.
A score of 100 to 399 signals a 10-year cardiovascular risk above 7.5 percent and points toward starting or intensifying a statin. A score of 1,000 or higher identifies a very-high-risk phenotype with event rates comparable to people who already have known heart disease.
The updated guideline also ties LDL-C targets to CAC results. Adults with a score of 100 to 299, or above the 75th percentile for age, have a treatment target below 70 mg/dL. Those with a score of 1,000 or higher have a target below 55 mg/dL.
Where the scan helps most
The JACC analysis showed CAC scoring adds the most clarity when the statin decision is genuinely uncertain. In the intermediate group, adults with any calcium had event rates roughly twice those with none.
Also read: Scientists mapped 830,000 immune cells in the Alzheimer's brain and found something unexpected
Among people already recommended for a statin under the guideline, event rates stayed high. That group ran at 16.6 per 1,000 person-years with any calcium and 5.8 with none, suggesting a zero score should not by itself be used to withhold statin therapy there.
The test itself is straightforward. A CAC scan uses a modern CT scanner and delivers an effective radiation dose of about 1 mSv, about a third of the average annual background exposure in the U.S.
Out-of-pocket costs typically run $100 to $400, according to GoodRx. Most insurance plans, including original Medicare, do not routinely cover it.
Limits worth knowing
The Frontiers in Radiology review noted that CAC scoring does not detect non-calcified plaque and should not be used as a rule-out test for obstructive coronary disease, particularly in symptomatic younger adults. A zero score also does not erase a high LDL-C reading on its own.
Also read: Kelly Rowland shares her top tips for easing eczema
For adults in their 40s to 70s weighing whether to start a statin, the 2026 guideline supports asking a doctor whether a CAC scan could sharpen the decision.
Also read: What's a healthy body fat percentage for your age? The ranges by sex and decade